Price
CHART BY
Historical dividends and forecast
The next dividend will be paid on 12.06.2026
$1.241
CHART BY
Frequently asked questions
What is Sanofi ADR Representing 1 1/2's market capitalization?
The market capitalization of Sanofi ADR Representing 1 1/2 is $139.07B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Sanofi ADR Representing 1 1/2's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Sanofi ADR Representing 1 1/2 is 13.36. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Sanofi ADR Representing 1 1/2?
Sanofi ADR Representing 1 1/2's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $4.239. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Sanofi ADR Representing 1 1/2's stock?
Currently, 6 analysts cover Sanofi ADR Representing 1 1/2's stock, with a consensus target price of $67.81. Analyst ratings provide insights into the stock's expected performance.
What is Sanofi ADR Representing 1 1/2's revenue over the trailing twelve months?
Over the trailing twelve months, Sanofi ADR Representing 1 1/2 reported a revenue of $58.87B.
What is the free float of Sanofi ADR Representing 1 1/2's shares?
The free float of Sanofi ADR Representing 1 1/2 is 2.42B. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $139.07B
- EPS (TTM)
- $4.239
- Free Float
- 2.42B
- P/E ratio (TTM)
- 13.36
- Revenue (TTM)
- $58.87B
Pricing
- 1D span
- $48.38$48.86
- 52W span
- $44.63$60.12
Analyst Ratings
The price target is $67.81 and the stock is covered by 6 analysts.
Buy
4
Hold
2
Sell
0
Information
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines and vaccines franchises plus support and corporate functions, for all geographical territories. The company was founded in 1973 and is headquartered in Paris, France.
- Industries
- Major Pharmaceuticals
- Sector
- Health Care
Identifier
- Primary Ticker
- SNY
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet